MANKINDNSEMANKIND PHARMA LIMITEDLowNeutral
Announced Fri, 17 Jul · 15:36 IST

Investor conference call for Q1 FY27 on 30 July 2026

Board & Shareholder Meetings View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.9%1-day move
₹2480.10
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.9+2.4+3.2+1.2+2.5
Up moveDown movePending
AI summary

Mankind Pharma will host an investor conference call on Thursday, 30 July 2026 at 6:30 PM IST to discuss Q1 FY27 business performance and results. The call will be held via Zoom. Senior management attending includes Vice Chairman Rajeev Juneja, CEO Sheetal Arora, COO Arjun Juneja, Global CFO Ashutosh Dhawan and President of Strategy Prakash Agarwal. Invite is also on the company website.

Likely market impact

Investors should watch Q1 FY27 results update on 30 July; the earnings call can move the stock based on guidance and performance.